BAX vs RGEN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 15, 2026

BAX

31.5
AI Score
VS
RGEN Wins

RGEN

33.4
AI Score

Investment Advisor Scores

BAX

32score
Recommendation
SELL

RGEN

33score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric BAX RGEN Winner
Forward P/E 14.245 79.3651 BAX
PEG Ratio 36.6767 2.1747 RGEN
Revenue Growth 5.3% 11.9% RGEN
Earnings Growth 36.8% -65.9% BAX
Tradestie Score 31.5/100 33.4/100 RGEN
Profit Margin -9.3% 5.3% RGEN
Beta 1.00 1.00 Tie
AI Recommendation SELL SELL Tie

Relative Price Performance (Last 90 Days)

BAX 1M: +21.6% · 3M: +38.4% RGEN 1M: +31.6% · 3M: +59.8%

Current Technical Phase

BAX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (15.1% over 20 days), RSI 57

RSI (14): 56.6 · Price: $26.34

RGEN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (12.9% over 20 days), RSI 77

RSI (14): 76.6 · Price: $181.13

Fundamentals Snapshot

Metric BAX RGEN
Market Cap
Forward P/E 12.9 68.3
Trailing P/E 226.1
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.3% 0.5%
Operating Margin 0.1% 0.1%
EPS -1.86 0.78
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, RGEN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.